Evolution of Cancer Pharmacological Treatments at the Turn of the Third Millennium
The medical history of cancer began millennia ago. Historical findings of patients with cancer date back to ancient Egyptian and Greek civilizations, where this disease was predominantly treated with radical surgery and cautery that were often ineffective, leading to the death of patients. Over the...
Saved in:
Main Authors: | Luca Falzone (Author), Salvatore Salomone (Author), Massimo Libra (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2018-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
In silico analysis of the solute carrier (SLC) family in cancer indicates a link among DNA methylation, metabolic adaptation, drug response, and immune reactivity
by: Alessandro Lavoro, et al.
Published: (2023) -
Cancer resistance via the downregulation of the tumor suppressors RKIP and PTEN expressions: therapeutic implications
by: Matthew Moghaddam, et al.
Published: (2023) -
Analytical and experimental pharmacology, challenges ahead
by: Salvatore eSalomone
Published: (2010) -
The PIK3CA H1047R Mutation Confers Resistance to BRAF and MEK Inhibitors in A375 Melanoma Cells through the Cross-Activation of MAPK and PI3K-Akt Pathways
by: Saverio Candido, et al.
Published: (2022) -
Editorial: Insights in Experimental Pharmacology and Drug Discovery: 2021
by: Andres Trostchansky, et al.
Published: (2022)